Motor Neuron Disease Treatment Market Size & Share, by Drug Class (Riluzole, Edaravone); End-user (Multidisciplinary Clinics, Hospitals, Social Work Facilities) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3781
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Companies Dominating the Motor Neuron Disease Treatment Landscape

top-features-companies
    • European Technologies Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Conscientia Industrial Co., Ltd
    • CSNpharm, Inc.
    • Aozeal Certified Standards (AOCS), Inc.
    • Finetech Industry Limited
    • Skyrun Industrial Co., Ltd.
    • Santa Cruz Biotechnology, Inc.
    • Amadis Chemical Company Limited
    • Mitsubishi Tanabe America, Inc.
    • Aquesituve Therapeutics

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Mitsubishi Tanabe Pharma America, Inc. announced that EXSERVAN, the first oral film formulation of riluzole, is now available in the United States for the treatment of amyotrophic lateral sclerosis (ALS).

  • Aquestive Therapeutics has granted Zambon Pharma a license to develop and commercialize an investigational oral formulation of riluzole for the treatment of ALS in the European Union.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3781
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of chronic diseases globally and growing levels of awareness about motor neuron diseases are the major factors driving the market growth.

The market size of motor neuron disease treatment is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023-2035

The requirement of high cost for treatment is estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are European Technologies Inc., Conscientia Industrial Co., Ltd, CSNpharm, Inc., Aozeal Certified Standards (AOCS), Inc., Finetech Industry Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug class, end user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying